Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
10/10/2022 | — | Cowen & Co. | Initiates Coverage On | → Outperform |
Third Harmonic Bio Questions & Answers
The latest price target for Third Harmonic Bio (NASDAQ: THRD) was reported by Cowen & Co. on October 10, 2022. The analyst firm set a price target for $0.00 expecting THRD to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.
The latest analyst rating for Third Harmonic Bio (NASDAQ: THRD) was provided by Cowen & Co., and Third Harmonic Bio initiated their outperform rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Third Harmonic Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Third Harmonic Bio was filed on October 10, 2022 so you should expect the next rating to be made available sometime around October 10, 2023.
While ratings are subjective and will change, the latest Third Harmonic Bio (THRD) rating was a initiated with a price target of $0.00 to $0.00. The current price Third Harmonic Bio (THRD) is trading at is $20.01, which is out of the analyst's predicted range.